TUZOF-S 1.5 GM: Powerful Cefoperazone 1000 mg + Sulbactam 500 mg Injection for Broad-Spectrum Infection Control

Introduction

TUZOF-S 1.5 GM is a high-efficacy broad-spectrum antibiotic injection from Amcare Biosciences, designed for strong clinical performance in moderate to severe bacterial infections.
This formulation contains:

• Sterile Cefoperazone Sodium IP (sterile) equivalent to Cefoperazone 1000 mg

• Sterile Sulbactam Sodium IP equivalent to Anhydrous Sulbactam 500 mg

The synergistic combination of Cefoperazone (a potent 3rd-generation cephalosporin) with Sulbactam (a β-lactamase inhibitor) enhances antibacterial coverage, overcomes resistance, and ensures fast therapeutic outcomes.

What is TUZOF-S 1.5 GM?

1. Cefoperazone Sodium IP

Equivalent to Cefoperazone 1000 mg

• A broad-spectrum 3rd-generation cephalosporin

• Strong activity against gram-positive and gram-negative pathogens

• Effective in severe respiratory, urinary, abdominal, skin, and systemic infections

• Acts by inhibiting bacterial cell wall synthesis

• A key component for managing mixed and resistant bacterial infections

2. Sulbactam Sodium IP

Equivalent to Anhydrous Sulbactam 500 mg

• A potent β-lactamase inhibitor

• Protects Cefoperazone from enzymatic degradation

• Enhances penetration and spectrum of activity

• Improves effectiveness against resistant and hospital-acquired infections

Key Benefits of TUZOF-S 1.5 GM

✔ Broad-spectrum antibacterial action
✔ Highly effective against β-lactamase–producing organisms
✔ Strong results in mixed and severe infections
✔ Faster symptomatic and clinical recovery
✔ Manufactured under strict sterile IP standards
✔ Trusted formulation by healthcare professionals

Indications

TUZOF-S 1.5 GM is commonly used to treat:

• Respiratory tract infections (pneumonia, bronchitis)

• Urinary tract infections (complicated UTIs)

• Intra-abdominal and pelvic infections

• Skin & soft tissue infections

• Biliary tract infections

• Bone & joint infections

• Septicemia

• Post-operative and hospital-acquired infections

How TUZOF-S 1.5 GM Works

Cefoperazone 1000 mg

• Inhibits bacterial cell wall synthesis

• Kills bacteria by disrupting structural integrity

• Shows strong action against gram-positive, gram-negative & anaerobic organisms

Sulbactam 500 mg

• Blocks β-lactamase enzymes

• Prevents Cefoperazone inactivation by resistant bacteria

• Broadens antibacterial spectrum for enhanced infection control

Together, they deliver fast, reliable, and long-lasting infection management.

Possible Side Effects

Common:

• Injection site pain

• Mild diarrhea

• Nausea

• Skin rash

Rare:

• Allergic reactions

• Severe diarrhea

• Elevated liver enzymes

Note: Should be administered only under medical supervision.

Amcare Biosciences – A Trusted PCD Pharma Company in Gujarat

Amcare Biosciences is a leading and rapidly growing PCD Pharma Company in Gujarat, offering a complete portfolio of pharmaceutical, ayurvedic, nutraceutical, and cosmetic formulations.
Renowned brands like TUZOF-S 1.5 GM, CEFXOBEES series, CILNIBIL series, LINABEES, and EMPAWITH highlight the company’s commitment to quality, purity, and therapeutic excellence.

The company also offers profitable PCD Pharma Franchise opportunities, enabling partners to grow with a reliable product portfolio and strong support.

Conclusion

TUZOF-S 1.5 GM, containing Cefoperazone 1000 mg + Sulbactam 500 mg, is a powerful and dependable broad-spectrum antibiotic injection.
Backed by the trusted standards of Amcare Biosciences, it ensures faster recovery, enhanced antibacterial coverage, and superior clinical outcomes in patients with moderate to severe infections.